297 related articles for article (PubMed ID: 26832214)
1. The Role of CD44 in Glucose Metabolism in Prostatic Small Cell Neuroendocrine Carcinoma.
Li W; Cohen A; Sun Y; Squires J; Braas D; Graeber TG; Du L; Li G; Li Z; Xu X; Chen X; Huang J
Mol Cancer Res; 2016 Apr; 14(4):344-53. PubMed ID: 26832214
[TBL] [Abstract][Full Text] [Related]
2. CD44 expression is a feature of prostatic small cell carcinoma and distinguishes it from its mimickers.
Simon RA; di Sant'Agnese PA; Huang LS; Xu H; Yao JL; Yang Q; Liang S; Liu J; Yu R; Cheng L; Oh WK; Palapattu GS; Wei J; Huang J
Hum Pathol; 2009 Feb; 40(2):252-8. PubMed ID: 18835619
[TBL] [Abstract][Full Text] [Related]
3. PC3 is a cell line characteristic of prostatic small cell carcinoma.
Tai S; Sun Y; Squires JM; Zhang H; Oh WK; Liang CZ; Huang J
Prostate; 2011 Nov; 71(15):1668-79. PubMed ID: 21432867
[TBL] [Abstract][Full Text] [Related]
4. CD44ICD promotes breast cancer stemness via PFKFB4-mediated glucose metabolism.
Gao R; Li D; Xun J; Zhou W; Li J; Wang J; Liu C; Li X; Shen W; Qiao H; Stupack DG; Luo N
Theranostics; 2018; 8(22):6248-6262. PubMed ID: 30613295
[TBL] [Abstract][Full Text] [Related]
5. Overlap of CD44 expression between prostatic small cell carcinoma and acinar adenocarcinoma.
Wang CC; De Marzo AM; Lotan TL; Epstein JI
Hum Pathol; 2015 Apr; 46(4):554-7. PubMed ID: 25656929
[TBL] [Abstract][Full Text] [Related]
6. FOXA2 is a sensitive and specific marker for small cell neuroendocrine carcinoma of the prostate.
Park JW; Lee JK; Witte ON; Huang J
Mod Pathol; 2017 Sep; 30(9):1262-1272. PubMed ID: 28621319
[TBL] [Abstract][Full Text] [Related]
7. Functional metabolic screen identifies 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 as an important regulator of prostate cancer cell survival.
Ros S; Santos CR; Moco S; Baenke F; Kelly G; Howell M; Zamboni N; Schulze A
Cancer Discov; 2012 Apr; 2(4):328-43. PubMed ID: 22576210
[TBL] [Abstract][Full Text] [Related]
8. Androgen-responsive and nonresponsive prostate cancer cells present a distinct glycolytic metabolism profile.
Vaz CV; Alves MG; Marques R; Moreira PI; Oliveira PF; Maia CJ; Socorro S
Int J Biochem Cell Biol; 2012 Nov; 44(11):2077-84. PubMed ID: 22964025
[TBL] [Abstract][Full Text] [Related]
9. CD44 regulates prostate cancer proliferation, invasion and migration via PDK1 and PFKFB4.
Li W; Qian L; Lin J; Huang G; Hao N; Wei X; Wang W; Liang J
Oncotarget; 2017 Sep; 8(39):65143-65151. PubMed ID: 29029419
[TBL] [Abstract][Full Text] [Related]
10. The metabolic role of PFKFB4 in androgen-independent growth in vitro and PFKFB4 expression in human prostate cancer tissue.
Li X; Chen Z; Li Z; Huang G; Lin J; Wei Q; Liang J; Li W
BMC Urol; 2020 Jun; 20(1):61. PubMed ID: 32487245
[TBL] [Abstract][Full Text] [Related]
11. p53 Mutation Directs AURKA Overexpression via miR-25 and FBXW7 in Prostatic Small Cell Neuroendocrine Carcinoma.
Li Z; Sun Y; Chen X; Squires J; Nowroozizadeh B; Liang C; Huang J
Mol Cancer Res; 2015 Mar; 13(3):584-91. PubMed ID: 25512615
[TBL] [Abstract][Full Text] [Related]
12. Modulation of glucose metabolism by CD44 contributes to antioxidant status and drug resistance in cancer cells.
Tamada M; Nagano O; Tateyama S; Ohmura M; Yae T; Ishimoto T; Sugihara E; Onishi N; Yamamoto T; Yanagawa H; Suematsu M; Saya H
Cancer Res; 2012 Mar; 72(6):1438-48. PubMed ID: 22293754
[TBL] [Abstract][Full Text] [Related]
13. Selective expression of CD44, a putative prostate cancer stem cell marker, in neuroendocrine tumor cells of human prostate cancer.
Palapattu GS; Wu C; Silvers CR; Martin HB; Williams K; Salamone L; Bushnell T; Huang LS; Yang Q; Huang J
Prostate; 2009 May; 69(7):787-98. PubMed ID: 19189306
[TBL] [Abstract][Full Text] [Related]
14. Glycolytic pyruvate regulates P-Glycoprotein expression in multicellular tumor spheroids via modulation of the intracellular redox state.
Wartenberg M; Richter M; Datchev A; Günther S; Milosevic N; Bekhite MM; Figulla HR; Aran JM; Pétriz J; Sauer H
J Cell Biochem; 2010 Feb; 109(2):434-46. PubMed ID: 19950199
[TBL] [Abstract][Full Text] [Related]
15. ROS signaling by NADPH oxidase 5 modulates the proliferation and survival of prostate carcinoma cells.
Höll M; Koziel R; Schäfer G; Pircher H; Pauck A; Hermann M; Klocker H; Jansen-Dürr P; Sampson N
Mol Carcinog; 2016 Jan; 55(1):27-39. PubMed ID: 25559363
[TBL] [Abstract][Full Text] [Related]
16. A glycolytic phenotype is associated with prostate cancer progression and aggressiveness: a role for monocarboxylate transporters as metabolic targets for therapy.
Pertega-Gomes N; Felisbino S; Massie CE; Vizcaino JR; Coelho R; Sandi C; Simoes-Sousa S; Jurmeister S; Ramos-Montoya A; Asim M; Tran M; Oliveira E; Lobo da Cunha A; Maximo V; Baltazar F; Neal DE; Fryer LG
J Pathol; 2015 Aug; 236(4):517-30. PubMed ID: 25875424
[TBL] [Abstract][Full Text] [Related]
17. Tumor microenvironment and metabolic synergy in breast cancers: critical importance of mitochondrial fuels and function.
Martinez-Outschoorn U; Sotgia F; Lisanti MP
Semin Oncol; 2014 Apr; 41(2):195-216. PubMed ID: 24787293
[TBL] [Abstract][Full Text] [Related]
18. PFKFB3-mediated glycolysis is involved in reactive astrocyte proliferation after oxygen-glucose deprivation/reperfusion and is regulated by Cdh1.
Lv Y; Zhang B; Zhai C; Qiu J; Zhang Y; Yao W; Zhang C
Neurochem Int; 2015 Dec; 91():26-33. PubMed ID: 26498254
[TBL] [Abstract][Full Text] [Related]
19. Expression analysis of putative stem cell markers in human benign and malignant prostate.
Ugolkov AV; Eisengart LJ; Luan C; Yang XJ
Prostate; 2011 Jan; 71(1):18-25. PubMed ID: 20583131
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-124 suppresses proliferation and glycolysis in non-small cell lung cancer cells by targeting AKT-GLUT1/HKII.
Zhao X; Lu C; Chu W; Zhang B; Zhen Q; Wang R; Zhang Y; Li Z; Lv B; Li H; Liu J
Tumour Biol; 2017 May; 39(5):1010428317706215. PubMed ID: 28488541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
